A prospective primary care study found that an AI-enabled digital stethoscope substantially improved sensitivity for detecting clinically significant valvular heart disease compared with standard auscultation.
The technology identified more previously undiagnosed moderate-to-severe disease but showed reduced specificity, highlighting a trade-off between earlier detection and potential false positives.